Direct effect of protein kinase C inhibitors on cardiovascular ion channels

BMB Reports

Volumn 44, Issue 9, 2011, Pages 559-565

  Son, Youn Kyoung ^a   Da Hong, Hye ^a   Kim, Dae Joong ^a   Firth, Amy L ^b   Park, Won Sun ^a  

^a Kangwon National University   (South Korea)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Bisindolylmaleimide (I); Chelerythrine; Ion channel; Protein kinase C; Ro 31 8220; Rottlerin; Staurosporine

Indexed keywords

BISINDOLYLMALEIMIDE I; INDOLE DERIVATIVE; ION CHANNEL; MALEIMIDE DERIVATIVE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; STAUROSPORINE;

CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; SHORT SURVEY; VASCULAR SMOOTH MUSCLE;

HUMANS; INDOLES; ION CHANNELS; MALEIMIDES; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; STAUROSPORINE;

EID: 83655190832     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2011.44.9.559     Document Type: Short Survey

References (55)

1. Divecha, N. and Irvine, R. F. (1995) Phospholipid signaling. Cell 80, 269-278.
2. Nishizuka, Y. (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB. J. 9, 484-496.
3. 2+ dependent protein kinase. Biochem. Biophys. Res. Commun. 135, 397-402.
4. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F., Duhamel, L., Charon, D. and Kirilovsky, J. (1991) The bisindolylmaleimide GF 109203X is potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781.
5. Roffey, J., Rosse, C., Linch, M., Hilbbert, A., McDonald, N. Q. and Parker, P. J. (2009) Protein kinase C intervention: the state of play. Curr. Opin. Cell Biol. 21, 268-279.
6. Furusaki, A., Hashiba, N., Matsumoto, T., Hirano, A., Iwai, Y. and Omura, S. (1978) X-Ray crystal structure of staurosporine: a new alkaloid from a Streptomyces strain. J. Chem. Soc. Chem. Commun. 18, 800-801.
7. Meggio, F., Donella Deana, A., Ruzzene, M., Brunati, A. M., Cesaro, L., Guerra, B., Meyer, T., Mett, H., Fabbro, D., Furet, P., Dobrowolska, G. and Pinna, L. A. (1995) Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2. Eur. J. Biochem. 234, 317-322.
8. Jirousek, M. R., Giling, J. R., Gonzalez, C. M., Heath, W. F., McDonald, J. H. 3rd, Neel, D. A., Rito, C. J., Singh, U., Stramm, L. E., Melikian-Badalian, A., Baevsky, M., Ballas, L. M., Hall, S. E., Winneroski, L. L. and Faul, M. M. (1996) (S)-13-[(dimethylamino) methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno-1H,13H-dibenzo [e,k] pyrrol [3,4-h] [1,4,13] oxadiazacyclohexadecene-1,3 (2H)-dione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. J. Med. Chem. 39, 2664-2671.
9. Green, L. J., Marder, P., Ray, C., Cook, C. A., Jaken, S., Musib, L. C., Herbst, R. S., Carducci, M., Britten, C. D., Basche, M., Eckhardt, S. G. and Thornton, D. (2006) Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor. Clin. Cancer Res. 12, 3408-3415.
10. Kobayashi, E., Ando, K., Nakano, H., Iida, T., Ohno, H., Morimoto, M. and Tamaoki, T. (1989) Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physic-chemical properties and biological activities. J. Antibiot (Tokyo). 42, 1470-1474.
11. Kazanietz, M. G., Lewin, N. E., Bruns, J. D. and Blumberg, P. M. (1995) Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor. Analysis of ligandbinding interactions, lipid cofactor requirements, and inhibitor sensitivity. J. Biol. Chem. 270, 10777-10783.
12. Bruns, R. F., Miller, F. D., Merriman, R. L., Howbert, J. J., Heath, W. F., Kobayashi, E., Takahashi, I., Tamaoki, T. and Nakano, H. (1991) Inhibition of protein kinase C by calphostin C is light-dependent. Biochem. Biophys. Res. Commun. 176, 288-293.
13. Churchill, E. N., Qvit, N. and Mochly-Rosen, D. (2009) Rationally designed peptide regulators of protein kinase C. Trends Endocrinol. Metab. 20, 25-33.
14. Herbert, J. M., Augereau, J. M., Gleye, J. and Maffrand, J. P. (1990) chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172, 993-999.
15. Eckly-Michel, A. E., Le Bec, A. and Lugnier, C. (1997) Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases. Eur. J. Pharmacol. 324, 85-88.
16. Zamora, M. A., Dempsey, E. C., Walchak, S. J. and Stelzner, T. J. (1993) BQ123, and ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 9, 429-433.
17. Newton, A. C. (1997) Regulation of protein kinase C. Curr. Opin. Cell Biol. 9, 161-167.
18. + current in rat intrapulmonary arterial myocytes by endothelin-1. Am. J. Physiol. 274, 842-853.
19. Li, P. F., Maasch, C., Haller, H., Dietz, R. and von Harsdorf, R. (1999) Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells. Circulation 100, 967-973.
20. Inoue, Y., Oike, M., Nakao, K., Kitamura, K. and Kuriyama, H. (1990) Endothelin augments unitary calcium channel currents on the smooth muscle cell membrane of guinea-pig portal vein. J. Physiol. 423, 171-191.
21. Van Renterghem, C. and Lazdunski, M. (1993) Endothelin and vasopressin activate low conductance chloride channels in aortic smooth muscle cells. Pflugers. Arch. 425, 156-163.
22. 2+ influx. J. Mol. Cell Cardiol. 28, 707-722.
23. Park, W. S., Ko, E. A., Han, J., Kim, N. and Earm, Y. E. (2005) Endothelin-1 acts via protein kinase C to block KATP channels in rabbit coronary and pulmonary arterial smooth muscle cells. J. Cardiovasc. Pharmacol. 45, 99-108.
24. + channels in rabbit coronary arterial smooth muscle cells through protein kinase C. J. Cardiovasc. Pharmacol. 46, 681-689.
25. + current through a PKC-independent mechanism in isolated coronary arterial smooth muscle cells. J. Cardiovasc. Pharmacol. 45, 260-269.
26. French, R. J. and Shoukimas, J. J. (1981) Blockage of squid axon potassium conductance by internal tetra-N-alkylammonium ions of various sizes. Biophys. J. 34, 271-291.
27. Hoshi, T., Zagotta, W. N. and Aldrich, R. W. (1990) Biophysical and molecular mechanisms of Shaker potas sium channel inactivation. Science 250, 533-538.
28. Heginbotham, L. and MacKinnon, R. (1992) The aromatic binding site for tetraethylammonium ion on potassium channels. Neuron 8, 483-491.
29. Snyders, D. J. and Yeola, S. W. (1995) Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ. Res. 77, 575-583.
30. + channel and its structural implications. Nature 403, 321-325.
31. Kageyama, M., Mori, T., Yanagisawa, T. and Taira, N. (1991) Is staurosporine a specific inhibitor of protein kinase C in intact porcine coronary arteries? J. Pharmacol. Exp. Ther. 259, 1019-1026.
32. 2+ current in rabbit atrial myocytes. Biochem. Biophys. Res. Commun. 329, 531-537.
33. Ko, J. H., Park, W. S., Kim, S. J. and Earm, Y. E. (2006) Slowing of the inactivation of voltage-dependent sodium channels by staurosporine, the protein kinase C inhibitor, in rabbit atrial myocytes. Eur. J. Pharmacol. 534, 48-54.
34. Narahashi, T. (1996) Neuronal ion channels as the target sites of insecticides. Pharmacol. Toxico. 79, 1-14.
35. Catterall, W. A. (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13-25.
36. Goldin, A. L. (2001) Resurgence of sodium channel research. Annu. Rev. Physiol. 63, 871-894.
37. + channels by staurosporine. Am. J. Physiol. 266, 1128-1132.
38. Choi, J. S., Hahn, S. J., Rhie, D. J., Jo, Y. H. and Kim, M. S. (1999) Staurosporine directly blocks Kv1.3 channels expressed in chinese hamster ovary cells. Naunyn Schmiedebergs Arch. Pharmacol. 359, 256-261.
39. Valenzuela, C., Delpon, E., Franqueza, L., Gray, P., Perez, O., Tamargo, J. and Snyders, D. J. (1996) Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation 94, 562-570.
40. + channels in coronary arterial smooth muscle cells. Life Sci. 77, 512-527.
41. + currents of rat mesenteric arterial smooth muscle. Eur. J. Pharmacol. 483, 117-126.
42. Voutilainen-Mylylä, S., Tavi, P. and Weckström, M. (2003) Chelerythrine and bisindolylmaleimide I prolong cardiac action potentials by protein kinase C-independent mechanism. Eur. J. Pharmacol. 466, 41-51.
43. + current by chelerythrine and bisindolylmaleimide I in atrial myocytes from mice. Eur. J. Pharmacol. 424, 173-178.
44. + channels in rabbit ventricular myocytes. Korean J. Physiol. Pharmacol. 14, 119-125.
45. Thomas, D., Hammerling, B. C., Wimmer, A. B., Wu, K., Ficker, E., Kuryshev, Y. A., Scherer, D., Kiehn, J., Katus, H. A., Schoels, W. and Karle, C. A. (2004) Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X). Cardiovasc. Res. 64, 467-476.
46. Ficker, E., Kuryshev, Y. A., Dennis, A. T., Obejero-Paz, C., Wang, L., Hawryluk, P., Wible, B. A. and Brown, A. M. (2004) Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol. Pharmacol. 66, 33-44.
47. Choi, B. H., Choi, J. S., Jeong, S. W., Hahn, S. J., Yoon, S. H., Jo, Y. H. and Kim, M. S. (2000) Direct block by bisindolylmaleimide of rat Kv1.5 expressed in chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 293, 634-640.
48. Lingameneni, R., Vysotskaya, T. N., Duch, D. S. and Hemmings, H. C. Jr. (2000) Inhibition of voltage-dependent sodium channels by Ro 31-8220, a 'specific' protein kinase C inhibitor. FEBS Lett. 473, 265-268.
49. Shi, L. and Wang, C. (1999) Inhibitory effect of the kinase inhibitor chelerythrine on acetylcholine-induced current in PC12 cells. Arch. Biochem. Biophys. 368, 40-44.
50. Murphy, C. T. and Westwick, J. (1992) Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses. Biochem. J. 283, 159-164.
51. Keenan, C., Goode, N. and Pears, C. (1997) Isoform specificity of activators and inhibitors of protein kinase C gamma and delta. FEBS Lett. 415, 101-108.
52. Zakharov, S. I., Morrow, J. P., Liu, G., Yang, L. and Marx, S. O. (2005) Activation of the BK (SLO1) potassium channel by mallotoxin. J. Biol. Chem. 280, 30882-30887.
53. + channels by rottlerin, an inhibitor of protein kinase C-delta, in pituitary tumor (GH3) cells and in cortical neuronal (HCN-1A) cells. J. Cell Physiol. 210, 656-666.
54. Butler, A., Tsunoda, S., McCobb, D. P., Wei, A. and Salkoff, L. (1993) mSlo, a complex mouse gene encoding "maxi" calcium-activated potassium channels. Science 261, 221-224.
55. Ghatta, S., Nimmagadda, D., Xu, X. P. and O'Rourke, S. T. (2006) Large-conductance, calcium-activated potassium channels: Structural and functional implications. Pharmacol. Ther. 110, 103-116.